| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6106861 | JAZZ | Multiparticulate tablet disintegrating in less than 40 seconds in the mouth |
Dec, 2017
(6 years ago) | |
| US6024981 | JAZZ | Rapidly dissolving robust dosage form |
Apr, 2018
(6 years ago) | |
| US6221392 | JAZZ | Rapidly dissolving robust dosage form |
Apr, 2018
(6 years ago) | |
Fazaclo Odt is owned by Jazz.
Fazaclo Odt contains Clozapine.
Fazaclo Odt has a total of 3 drug patents out of which 3 drug patents have expired.
Expired drug patents of Fazaclo Odt are:
- US6106861
- US6024981
- US6221392
Fazaclo Odt was authorised for market use on 30 May, 2007.
Fazaclo Odt is available in tablet, orally disintegrating;oral dosage forms.
The generics of Fazaclo Odt are possible to be released after 09 April, 2018.
Drugs and Companies using CLOZAPINE ingredient
Market Authorisation Date: 30 May, 2007
Treatment: NA
Dosage: TABLET, ORALLY DISINTEGRATING;ORAL
How can I launch a generic of FAZACLO ODT before it's drug patent expiration?
More Information on Dosage
FAZACLO ODT family patents
